- Aspira Women's Health Inc. announced an equity capital infusion totaling **$3.06 million** from existing and new investors.  **[926617_0001493152-25-013987_ex99-1.htm:0]** 
- This infusion comprises a **$2.95 million** private placement and a **$112,500** warrant exercise.  **[926617_0001493152-25-013987_ex99-1.htm:0]** 
- The private placement, which closed on **September 17, 2025**, involved the issuance of **6,550,000 additional common shares** and **4,912,500 new warrants** at a unit price of **$0.45**.  **[926617_0001493152-25-013987_ex99-1.htm:0]** **[926617_0001493152-25-013987_form8-k.htm:1]** 
- The warrants are exercisable at **$0.75** per share and have a **five-year** term.  **[926617_0001493152-25-013987_ex99-1.htm:0]** **[926617_0001493152-25-013987_form8-k.htm:1]** 
- Net proceeds from the offering will be used to support ongoing commercial activities, general corporate purposes, and working capital.  **[926617_0001493152-25-013987_ex99-1.htm:0]** **[926617_0001493152-25-013987_form8-k.htm:1]** **[926617_0001493152-25-013987_ex10-1.htm:26]**

Aspira Women's Health (AWHL)